Abu Dhabi’s Burjeel Holdings is set to expand its healthcare footprint by establishing a specialist oncology network across the Gulf Cooperation Council (GCC) region. This initiative aims to enhance cancer care accessibility and quality for patients in the UAE and neighboring countries.
Overview of Burjeel Holdings
Burjeel Holdings, a prominent healthcare provider in the Middle East and North Africa (MENA) region, has made significant strides in oncology care. Its flagship facility, Burjeel Medical City (BMC), is recognized as a Center of Excellence for Oncology Care and has been accredited by the European Society for Medical Oncology (ESMO) as an Integrated Oncology and Palliative Care Center. This accreditation underscores BMC’s commitment to providing comprehensive cancer treatment, including medical, surgical, radiation oncology, and nuclear medicine services.
The Need for a Specialist Oncology Network
Cancer remains a leading health challenge in the UAE, accounting for approximately 10% of all deaths. The UAE government has set ambitious goals to reduce cancer mortality by nearly 18% by 2025. Despite advancements in cancer care over the past few decades, significant disparities exist across treatment centers in terms of quality and access. Establishing a specialized oncology network will address these gaps by providing standardized care and improving patient outcomes.
Expansion Plans
The new oncology network will include multiple facilities across the GCC, focusing on delivering advanced cancer treatments that meet international standards. Burjeel aims to replicate the successful model established at BMC, which serves over 5,000 oncology patients annually and conducts more than 10,000 screenings each year. The network will leverage Burjeel’s expertise in personalized cancer medicine, having recently joined the Worldwide Innovative Networking in Personalized Cancer Medicine (WIN) Consortium. This membership will facilitate collaboration with global experts to accelerate the research and development of innovative therapies.
Comprehensive Cancer Care
The proposed oncology network will offer a wide range of services tailored to meet the diverse needs of cancer patients. These services will include:
- Early Detection and Screening: Implementing state-of-the-art screening techniques to ensure early diagnosis.
- Personalized Treatment Plans: Utilizing genetic information to create customized treatment strategies for patients.
- Palliative Care: Providing comprehensive support for patients throughout their treatment journey.
- Clinical Trials: Expanding access to clinical trials for cutting-edge therapies.
Burjeel’s commitment to holistic care ensures that patients receive medical treatment and emotional and psychological support during their journey.
Enhancing Accessibility
One of the primary goals of this new network is to improve accessibility for cancer patients across the GCC. By establishing multiple centers in strategic locations, Burjeel aims to reduce travel times and associated costs for patients seeking treatment. This initiative is particularly vital in regions where access to specialized oncology services is limited.
Collaboration with Local Healthcare Providers
To ensure the success of this initiative, Burjeel Holdings plans to collaborate with local healthcare providers across the GCC. By partnering with established hospitals and clinics, Burjeel can integrate its oncology services into existing healthcare frameworks, enhancing overall patient care. These collaborations will also facilitate knowledge-sharing and training opportunities for healthcare professionals in the region.
Commitment to Research and Innovation
Research plays a crucial role in advancing cancer care. Burjeel’s membership in the WIN Consortium positions it at the forefront of global oncology research efforts. The consortium focuses on developing personalized therapies based on genetic profiling, which can significantly improve treatment outcomes for cancer patients. Through this partnership, Burjeel aims to contribute to groundbreaking research initiatives that can benefit patients in the GCC worldwide.
Future Outlook
As Burjeel Holdings embarks on this ambitious project, it remains dedicated to its mission of providing world-class healthcare services. The establishment of a specialist oncology network aligns with the UAE government’s vision of becoming a regional hub for healthcare excellence. By prioritizing patient-centered care and leveraging advanced medical technologies, Burjeel aims to set new standards in oncology across the GCC.
Burjeel Holdings’ plans to build a specialist oncology network in the GCC represent a significant step forward in enhancing cancer care accessibility and quality in the region. With its commitment to innovation, collaboration, and comprehensive patient support, Burjeel is poised to make a lasting impact on the fight against cancer. As this initiative unfolds, it promises to transform the landscape of oncology care not only within the UAE but also throughout the Gulf region.
